Background: Pyrazoles, thiazoles and 1,3,4-thiadiazoles have been reported to possess various pharmacological activities.
Background
Multi-component reactions (MCR) are one-pot processes with at least three components to form a single product, which incorporates most or even all of the starting materials [1] [2] [3] [4] [5] [6] . The huge interest for such multi-component reactions during the last years has been oriented towards developing combinatorial chemistry procedures, because of their high efficiency and convenience of these reactions in comparison with multistage procedures. Also, the utility of MCR under microwave irradiation in synthesis of heterocyclic compounds enhanced the reaction rates and improve the regioselectivity [7] [8] [9] [10] [11] [12] .
On the other hand, pyrazole and its derivatives have drawn considerable attention of the researchers in the past few decades owing to their high therapeutic values. Some of the drugs, possessing pyrazole as basic moiety, like celecoxib [13] , deracoxib [14] , etoricoxib and atorivodine [15] are already booming in the market. Pyrazole derivatives possess an extensive range of pharmacological activities such as antiinflammatory, antipyretic, analgesic, antimicrobial, sodium channel blocker, antitubercular, antiviral, antihypertensive, antiglaucoma, antioxidant, antidepressant, anxiolytic, neuroprotective and antidiabetic activity [16] [17] [18] [19] [20] [21] [22] [23] . Furthermore, pyrazole prodrugs have also been reported to possess significant anticancer activities [24] [25] [26] [27] [28] [29] [30] . Keeping this in mind, and in continuation of our previous work on the synthesis of new anticancer agents [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] , we herein present an efficient regioselective synthesis of novel 4-heteroaryl-pyrazoles, which have not been reported hitherto in a multicomponent synthesis under microwave irradiation and to assess their anticarcinogenic effects against hepatocellular carcinoma (HepG-2) and human lung cancer (A-549) cell lines. 1 H NMR spectrum of the product revealed a singlet signal at 9.67 ppm assigned for isoxazole-5H proton not isoxazole-4H proton [42] [43] [44] 46] which consistent with the isomeric structure 13 rather than the isomeric structure 15. Moreover, the mass spectrum of 13a and 13b revealed a molecular ion peaks at m/z = 506 and 446, respectively, which is consistent with their molecular weights.
Furthermore, alternative synthesis of compound 13a was achieved via reaction enaminone 9 with N-hydroxy-2-naphthimidoyl chloride (10a) under the same reaction condition to yield authentic product 13a (Scheme 2).
Next, our study was extended to investigate the reactivity of compound 1 towards thiosemicarbazide and various hydrazonoyl halides aiming to synthesize new pyrazole based-1,3-thiazoles and 1,3,4-thiadiazoles. Thus, acetyl pyrrole 1, thiosemicarbazide 2 and α-keto hydrazonoyl halides 3a, b, e were allowed to react in a one-pot threecomponent reaction in dioxane containing catalytic amount of TEA under MWI to afford the arylazothiazole derivatives 18a-c, respectively (Scheme 3; Table 1 ). The reaction goes in parallel to literature [32, [35] [36] [37] .
The structure of the products 18a-c was assigned based on the spectral data and elemental analyses. For example mass spectrum of compound 18a revealed molecular ion peak at m/z 542 and its 1 H NMR spectrum exhibited four characteristic singlet signals at 2.32, 2.36, 2.48 and 10.47 assignable to three CH 3 groups and NH protons, respectively, in addition to an aromatic multiplet in the region 6.99-7.93 ppm equivalent to 12 protons. Its IR spectra showed one NH group band at 3396 cm −1 . The structure of products 18 was further confirmed by an alternative method. Thus, reaction of acetylpyrazole 1 with thiosemicarbazide 16 under MWI in ethanol containing drops of concentrated HCl led to the formation of product 19. Compound 19 was then react with 2-oxo-N-phenylpropanehydrazonoyl chloride (3a) in dioxane containing catalytic amount of TEA under MWI to give a product identical in all respects (IR, mp and mixed mp.) with 18a (Scheme 3).
In a similar manner, when acetyl pyrazole 1 was allowed to react with thiosemicarbazide 2 and ethyl (N-arylhydrazono)-chloroacetates 3c, f in dioxane in the presence of triethylamine under MWI, it afforded in each case a single isolable product, namely, 2- Table 1 ). Structure 21 was confirmed by elemental analysis, spectral data (IR, 1 H NMR, and mass), and alternative synthesis route. Thus, thiosemicarbazone 19 was reacted with ethyl)-2-chloro-2-(2-phenylhydrazono)acetate (3c) in dioxane in the presence of TEA under MWI afforded a product identical in all aspects (mp, mixed mp, and spectra) with 21a (Scheme 4).
Finally, the reactivity of acetylpyrazole 1 towards hydrazonoyl halides, be bereft of a-keto group, was examined. In the present study, we have established that reaction of acetylpyrazole 1 with N-thiosemicarbazide 16 and aryl carbohydrazonoyl chlorides 3d, g gave the respective 1,3,4-thiadiazoles 23a, b as the end products (Scheme 5; Table 1 ). The structures of compounds 23a, b were confirmed on the bases of spectral data and elemental analyses (see Experimental part). The reaction proceeded via S-alkylation, with removal of hydrogen chloride, to give S-alkylated intermediates 22 followed by intramolecular Michael type addition under the employed reaction conditions, followed by elimination of ammonia, afforded the final product 23 [36, 47] (Scheme 5).
Cytotoxic activity
The in vitro growth inhibitory activity of the synthesized compounds 6a-d, 9, 13a, b, 18a-c, 19, 21a, b and 23a, b was investigated against two carcinoma cell lines: human lung cancer (A-549) and human hepatocellular carcinoma(HepG-2) in comparison with the wellknown anticancer standard drug (cisplatin) under the same conditions using colorimetric MTT assay. Data generated were used to plot a dose response curve of which the concentration of test compounds required to kill 50% of cell population (IC 50 ) was determined. The results revealed that all the tested compounds showed inhibitory activity to the tumor cell lines in a concentration dependent manner. Interestingly, the results represented in Table 2 and Fig. 1 showed that compounds 13a, 13b and 21a were the most active compounds (IC 50 value of 4.47 ± 0.3, 3.46 ± 0.6, 3.10 ± 0.8 μg/mL, respectively) against the lung carcinoma cell line (A549), compared with cisplatin reference drug with IC 50 value of 0.95 ± 0.23 μg/mL. Moreover, the order of activity against A549 cell line was 18c
On the other hand, compounds 6a, 9, 13b, 23b were the most active compounds (IC 50 value of 5.60 ± 0.8, 5.67 ± 1.2, 4.47 ± 0.9 and 5.67 ± 1.2 μg/mL, respectively) against liver carcinoma cell line (HepG2) cell line while the rest compounds have moderate activities.
Experimental

Chemistry General
Melting points were measured on an Electrothermal IA 9000 series digital melting point apparatus (Bibby Sci. Lim. Stone, Staffordshire, UK). IR spectra were measured on PyeUnicam SP 3300 and Shimadzu FTIR 8101 PC infrared spectrophotometers (Shimadzu, Tokyo, Japan) in potassium bromide discs. NMR spectra were measured on a Varian Mercury VX-300 NMR spectrometer (Varian, Inc., Karlsruhe, Germany) operating at 300 MHz ( 1 H-NMR) and run in deuterated dimethylsulfoxide (DMSO-d 6 ). Chemical shifts were related to that of the solvent. Mass spectra were recorded on a Shimadzu GCMS-QP1000 EX mass spectrometer (Tokyo, Japan) at 70 eV. Elemental analyses were measured by using a German made Elementarvario LIII CHNS analyzer. Antitumor activity of the products was measured at the Regional Center for Mycology and Biotechnology at Al-Azhar University, Cairo, Egypt. Hydrazonoyl halides 3a-g were prepared following literature method [41, 48] .
Synthetic procedures
Synthesis of trisubstituted pyrazoles 6a-d and isoxazoles 13a,b Method
A To a stirred solution of acetyl pyrazole 1 (0.327 g, 1 mmol), dimethylformamide dimethylacetal 2 (1 mmol) and the appropriate hydrazonoyl halides 3a-d or hyroximoyl chlorides 10a, b (1 mmol) in dry toluene (15 mL), an equivalent amount of triethylamine (0.5 mL) was added. The reaction mixture was heated under reflux for 10-15 h (monitored through TLC). The precipitated triethylamine hydrochloride was filtered off, and the filtrate was evaporated under reduced pressure. The residue was triturated with MeOH. The solid product, so formed in each case, was collected by filtration, washed with water, dried, and crystallized from the proper solvent to afford the corresponding pyrazole 6a-d and isoxazole derivatives 13a, b, respectively.
Method B Repetition of the same reactions of method A with heating in microwave oven at 500 W and 150 °C for 4-10 min., gave products identical in all respects with those separated from method A. The products 6a-d and 13a, b together with their physical constants are listed below. (9) . Amixture of acetyl pyrazole 1 (3.27 g, 10 mmol) and dimethylformamide-dimethylacetal (DMF-DMA) (10 mmol) in dry toluene (20 mL) was refluxed in microwave oven at 500 W and 150 °C for 5 min., then left to cool to room temperature. The precipitated product was filtered off, washed with light petroleum (40-60 °C), and dried. Recrystallization from benzene afforded enaminone 1 as orange solid, mp 250-252 °C; IR (KBr) ν max 1642 (C=O), 2920, 3080 (C-H) cm Alternate synthesis of 6a and 13a Equimolar amounts of enaminone 9 (0.382 g, l mmol) and hydrazonoyl halide 3a or hyroximoyl chloride 10a (1 mmol) in dry toluene (15 mL) containing an equivalent amount of triethylamine (0.5 mL) was refluxed in microwave oven at 500 W and 150 °C for 6 min., gave products identical in all respects (mp, mixed mp and IR spectra) with compounds 6a and 13a, respectively. Method B Repetition of the same reactions of method A with heating in microwave oven at 500 W and 150 °C for 4-10 min., gave products identical in all respects with those separated from method A. The products 18a-c, 21a, b and 23a, b together with their physical constants are listed below. 12.0, 14.3, 15.7, 26.8 (CH 3 ), 105.3, 111.5, 114.9, 116.3,  117.9, 119.8, 120.8, 122.2, 126.4, 126.6, 127.9, 128.1, 131.9,  132.6, 137.6, 141.7, 142.1, 142.3 
1-(4-(5-Methyl-1-(4-nitrophenyl)-3-(thiophen-2-yl)-1H-pyrazole-4-carbonyl)-1-phenyl-1H-pyrazol-3-yl)ethanone (6a)
1-(4-(5-Methyl-1-(4-nitrophenyl)-3-(thiophen-2-yl)-1H -pyrazole-4-carbonyl)-1-(p-tolyl)-1H-pyrazol-3-yl)ethanone (6b)
Synthesis of 3-(dimethylamino)-1-(5-methyl-1-(4-nitroph enyl)-3-(thiophen-2-yl)-1H-pyrazol-4-yl)prop-2-en-1-one
(5-Methyl-1-(4-nitrophenyl)-3-(thiophen-2-yl)-1H-pyrazol-4-yl)(3-(naphthalen-2-yl)isoxazol-4-yl)methanone (13a)
Yellow
(3-(Furan-3-yl)isoxazol-4-yl)(5-methyl-1-(4-nitroph enyl)-3-(thiophen-2-yl)-1H-pyrazol-4-yl)methanone (13b)
Synthesis of thiazoles
4-Methyl-2-(2-(1-(5-methyl-1-(4-nitrophenyl)-3 -( t hi o p h e n -2 -yl) -1 H -p y ra z o l -4 -yl) e t hyli d e n e) hydrazinyl)-5-(phenyldiazenyl)thiazole (18a)
4-Methyl-2-(2-(1-(5-methyl-1-(4-nitrophenyl)-3-(thiophe n-2-yl)-1H-pyrazol-4-yl)ethylidene) hydrazinyl)-5-(p-tolyldiazenyl)thiazole (18b
5-((4-Chlorophenyl)diazenyl)-4-methyl-2-(2-(1-(5-meth yl-1-(4-nitrophenyl)-3-(thiophen-2-yl)-1H-pyrazol-4-yl) ethylidene)hydrazinyl)thiazole (18c)
Synthesis of 2-(1-(5-methyl-1-(4-nitrophenyl)-3-(thioph en-2-yl)-1H-pyrazol-4-yl)ethylidene) hydrazinecarbothioamide (19)
Amixture of acetyl pyrazole 1 (3.27 g, 10 mmol) and thiosemicarbazide 16 (0.91 g, 10 mmol) in ethanol (20 mL) containing catalytic amounts of concentrated HCl was refluxed in microwave oven at 500 W and 150 °C for 6 min., then left to cool to room temperature. The precipitated product was filtered off, washed with ethanol, and dried. -3-yl)-2,3-dihydro-1,3 Alternate synthesis of thiazole 18a and 21a Equimolar amounts of thiosemicarbazone 19 (0.400 g, l mmol) and hydrazonoyl chloride 3a or 3c (1 mmol) in dioxane (15 mL) containing an equivalent amount of triethylamine (0.05 mL) was refluxed in microwave oven at 500 W and 150 °C for 3 min., gave product identical in all respects (mp, mixed mp and IR spectra) with compounds 18a and 21a, respectively.
2-(2-(1-(5-Methyl-1-(4-nitrophenyl)-3-(thiophen-2-yl)-1H -pyrazol-4-yl)ethylidene) hydrazinyl)-5-(2-phenylhydrazono)thiazol-4(5H)-one (21a)
2-(2-(1-(5-Methyl-1-(4-nitrophenyl)-3-(thiophen-2-yl)-1H -pyrazol-4-yl)ethylidene) hydrazinyl)-5-(2-(p-tolyl)hydrazono)thiazol-4(5H)-one (21b)
2-((1-(
5-Methyl-1-(4-nitrophenyl)-3-(thiophen-2-yl)-1H- pyrazol-4-yl)ethylidene)hydrazono)-3,5-diphenyl-2,3-di- hydro-1,
2-((1-(5-Methyl-1-(4-nitrophenyl)-3-(thiophen-2-yl)-1H-pyrazol-4-yl)ethylidene) hydrazono)-3-(4-nitroph enyl)-5-(thiophen
Biological activity Anticancer activity
The cytotoxic evaluation of the synthesized compounds was carried out at the Regional Center for Mycology and Biotechnology at Al-Azhar University, Cairo, Egypt according to the reported method [49] .
Conclusion
In our present work, we herein present an efficient regioselective synthesis of novel 4-heteroaryl-pyrazoles, which have not been reported hitherto in a multicomponent synthesis under microwave irradiation. The structures of the newly synthesized compounds were established on the basis of spectroscopic evidences and their synthesis by alternative methods. The in vitro growth inhibitory activity of the synthesized compounds against hepatocellular carcinoma (HepG-2) and human lung cancer (A-549) cell lines were investigated in comparison with Cisplatin reference drug as a standard drug using MTT assay and the results revealed promising activities of six compounds.
